DHP Malaria - 搜索

约 357,000 个结果

在新选项卡中打开链接

nih.gov
https://pmc.ncbi.nlm.nih.gov › articles
Therapeutic Response to Dihydroartemisinin–Piperaquine for P ...
Dihydroartemisinin–piperaquine (DHP) has been the first-line treatment of uncomplicated malaria due to both Plasmodium falciparum and Plasmodium vivax infections in Papua, Indonesia, …
来自pmc.ncbi.nlm.nih.gov的其他内容
展开
nih.gov
https://pmc.ncbi.nlm.nih.gov › articles
Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant ...
Artemisinin combination therapy (ACT) is recommended for the treatment of multidrug resistant malaria in the second and third trimesters of pregnancy, but the experience with ACTs is …
- PubMed
plos.org
https://journals.plos.org › plosone › article
Efficacy and Safety of Dihydroartemisinin-Piperaquine …
2013年12月3日 · Findings document that DHP is more efficacious than CQ and AL in treating uncomplicated P. vivax malaria. The better safety profile of DHP and the once-daily dosage improves adherence, and its fixed co-formulation …
nih.gov
https://pmc.ncbi.nlm.nih.gov › articles
Dihydroartemisinin‐piperaquine for treating …
If left untreated, uncomplicated malaria can develop into severe malaria with kidney failure, breathing difficulties, fitting, unconsciousness, and eventually death. DHA‐P is one of five artemisinin‐based combination therapies the …
PubMed
https://pubmed.ncbi.nlm.nih.gov
Observation of Malaria Treatment with Dihydroartemisinin …
2022年5月23日 · Objective: Dihydroartemisinin-Piperaquine (DHP) combination is the first-line treatment for uncomplicated malaria in Indonesia and has been used since 2010. This study …
msf.org
https://medicalguidelines.msf.org › en › viewport › ...
DIHYDROARTEMISININ/PIPERAQUINE = DHA/PPQ oral
Completion treatment following parenteral therapy for severe malaria Forms and strengths Co-formulated tablets of dihydroartemisinin (DHA)/piperaquine (PPQ), in blister pack, for a …
其他用户还问了以下问题
Is dihydroartemisinin-piperaquine a first-line treatment for uncomplicated malaria in?
Turkiye Parazitol Derg. 2022 May 23;46 (2):102-107. doi: 10.4274/tpd.galenos.2021.54264. Objective: Dihydroartemisinin-Piperaquine (DHP) combination is the first-line treatment for uncomplicated malaria in Indonesia and has been used since 2010.
Observation of Malaria Treatment with Dihydroartemisinin-Piperaquine
pubmed.ncbi.nlm.nih.gov
Can DHP be used for uncomplicated P falciparum malaria?
DHP has recently been added to the list of ACT options recommended for the treatment of uncomplicated P. falciparum malaria .
Efficacy and Safety of Dihydroartemisinin-Piperaquine for ... - PLOS
journals.plos.org
Can DHP be used as an alternative antimalarial drug?
DHP has the potential to become an alternative antimalarial drug for the treatment uncomplicated P. vivax malaria. This should be substantiated by future RCTs with other ACTs. Additional work is required to establish how best to combine this treatment with appropriate antirelapse therapy (primaquine or other drugs under development).
Efficacy and Safety of Dihydroartemisinin-Piperaquine for ... - PLOS
journals.plos.org
Is DHAP effective against uncomplicated malaria?
The efficacy of DHA‐P against uncomplicated P. falciparum malaria in adults and children however is now well established, and although there is only limited data from South America, it is likely that the findings of this review can be applied worldwide.
Dihydroartemisinin‐piperaquine for treating uncomplicated
pmc.ncbi.nlm.nih.gov
Is DHP a safe treatment for malaria during pregnancy?
Of the 1217 women admitted with malaria in the second and third trimesters without an impending adverse outcome, those treated with DHP were more likely to be discharged with an ongoing pregnancy compared to those treated with a non-ACT regimen (Odds Ratio OR = 2.48 [1.26–4.86]); p = 0.006.
Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant
pmc.ncbi.nlm.nih.gov
How often do patients with uncomplicated malaria take DHP tablets?
Patients with uncomplicated malaria were administered supervised DHP tablets once daily for 3 days. Clinical and laboratory data were collected daily until parasite clearance and then weekly for 6 weeks. Molecular analysis was undertaken for all patients with recurrent parasitemia. A total of 129 study patients were enrolled in the study.
Therapeutic Response to Dihydroartemisinin–Piperaquine for P
pmc.ncbi.nlm.nih.gov
反馈
PubMed
https://pubmed.ncbi.nlm.nih.gov
Efficacy and safety of dihydroartemisinin-piperaquine for …
2013年12月3日 · Findings document that DHP is more efficacious than CQ and AL in treating uncomplicated P. vivax malaria. The better safety profile of DHP and the once-daily dosage …
Malaria Journal
https://malariajournal.biomedcentral.com › articles
Efficacy and safety of dihydroartemisinin–piperaquine for the …
2022年3月19日 · Dihydroartemisinin–piperaquine (DHA–PPQ) has been adopted as first-line therapy for uncomplicated falciparum malaria in Indonesia since 2010. The efficacy of …
PubMed
https://pubmed.ncbi.nlm.nih.gov
Therapeutic Response to Dihydroartemisinin-Piperaquine for P
Dihydroartemisinin-piperaquine (DHP) has been the first-line treatment of uncomplicated malaria due to both Plasmodium falciparum and Plasmodium vivax infections in Papua, Indonesia, …
nih.gov
https://pmc.ncbi.nlm.nih.gov › articles
Clinical and Pharmacological Determinants of the Therapeutic …
Dihydroartemisinin-piperaquine (DHP) is an important new treatment for drug-resistant malaria, although pharmacokinetic studies on the combination are limited. In Papua, Indonesia, we …

某些结果已被删除
分页
- 1
- 2
- 3
- 4
- 下一页